ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,274.40
      -0.10%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.395
      -0.15%
      Bitcoin
      66,984.47
      -0.92%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Phaxiam Therapeutics (0QSS) Quote

      Phaxiam Therapeutics

      Phaxiam Therapeutics (0QSS)

      LSE
      71.025
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      71.025
      Bid
      6.925
      Ask
      7.28
      Volume
      0.00
      0.00 Day's Range 0.00
      71.025 52 Week Range 71.025
      Market Cap
      4.315B
      Previous Close
      71.025
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      30
      Shares Outstanding
      60,751,000
      Dividend Yield
      -
      PE Ratio
      -5.10
      Earnings Per Share (EPS)
      -0.39
      Revenue
      1.33M
      Net Profit
      -23.49M

      About Phaxiam Therapeutics

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.phaxiam.com
      Headquarters
      Lyon, Rhone, Fra
      Founded
      1970
      Phaxiam Therapeutics is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QSS. The last closing price for Phaxiam Therapeutics was 71.03 €. Over the last year, Phaxiam Therapeutics shares have traded in a share price range of 71.025 € to 71.025 €.

      Phaxiam Therapeutics currently has 60,751,000 shares outstanding. The market capitalization of Phaxiam Therapeutics is 4.31 € billion. Phaxiam Therapeutics has a price to earnings ratio (PE ratio) of -5.10.

      0QSS Latest News

      More News

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024 Article 223-16 du Règlement Général de l’Autorité des Marchés...

      July 03 2024
      GlobeNewswire Inc.

      Résultats de l'Assemblée Générale Mixte du 28 juin 2024

      Résultats de l'Assemblée Générale Mixte du 28 juin 2024 Lyon (France) et Cambridge (MA, US), le 28 juin 2024 – 17h45 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société...

      June 28 2024
      GlobeNewswire Inc.

      PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€

      PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€ Lyon (France), le 27 juin 2024 - 17h45 CEST - PHAXIAM...

      June 27 2024
      GlobeNewswire Inc.

      Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extension

      Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause...

      June 12 2024
      GlobeNewswire Inc.

      PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024

      PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024 Lyon (France) et Cambridge (MA, US), le 7 juin 2024 – 17h45 CEST –...

      June 07 2024
      GlobeNewswire Inc.

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024 Article 223-16 du Règlement Général de l’Autorité des Marchés...

      June 05 2024
      GlobeNewswire Inc.

      PHAXIAM provides Business and Financial Update for the First Quarter of 2024

      PHAXIAM provides Business and Financial Update for the First Quarter of 2024 PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15...

      May 15 2024
      GlobeNewswire Inc.

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024   Article 223-16 du Règlement Général de l’Autorité des Marchés...

      May 03 2024
      GlobeNewswire Inc.

      PHAXIAM Announces 2023 Full-Year Results and Provides Business Update

      PHAXIAM Announces 2023 Full-Year Results and Provides Business Update Conference call and webcast (English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CET Ongoing clinical efforts boding...

      March 20 2024
      UK Regulatory

      PHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activités

      PHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activités Webinaire en français le jeudi 21 mars 2024 à 11h00 CET : inscrivez-vous ici Stratégie clinique en phase...

      March 20 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40071.02571.02571.025271.025DE
      120071.02571.02571.0253071.025DE
      260071.02571.02571.0252271.025DE
      520071.02571.02571.025270071.025DE
      1560071.02571.02571.025703071.025DE
      2600071.02571.02571.025488571.025DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NMHINatures Miracle Holding Inc
      $ 0.80
      (128.57%)
      		7.43M
      WRNTWarrantee Inc
      $ 0.6345
      (118.04%)
      		6.35M
      FEIMFrequency Electronics Inc
      $ 13.50
      (33.66%)
      		106.13k
      LGHLWLion Group Holding Ltd
      $ 0.0092
      (29.58%)
      		4.08k
      TUSKMammoth Energy Services Inc
      $ 4.53
      (29.43%)
      		47.15k
      RNAZTransCode Therapeutics Inc
      $ 0.31
      (-60.88%)
      		406.18k
      MIRAMIRA Pharmaceuticals Inc
      $ 3.57
      (-28.74%)
      		906.3k
      CMAXCareMax Inc
      $ 3.87
      (-25.43%)
      		311.55k
      BREABrera Holdings PLC
      $ 0.578
      (-21.58%)
      		1.73M
      NUKKNukkleus Inc
      $ 0.3958
      (-20.52%)
      		146.88k
      NMHINatures Miracle Holding Inc
      $ 0.7961
      (127.46%)
      		7.44M
      WRNTWarrantee Inc
      $ 0.6165
      (111.86%)
      		6.4M
      LIFWMSP Recovery Inc
      $ 0.553
      (9.14%)
      		4.19M
      BREABrera Holdings PLC
      $ 0.578
      (-21.58%)
      		1.73M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 14.52
      (1.61%)
      		1.42M

      Discussion

      View Full Feed
      mfaphoto mfaphoto 28 seconds ago
      But the fee to buy them is $6.95, so they will cost you about 4 cents each.
      NSAV
      Awl416 Awl416 38 seconds ago
      Boy that “Seasoned” Investment Banker Dan McClory sure getting crushed here
      BREA
      LetGoodTimesRoll LetGoodTimesRoll 1 minute ago
      The MAN SAID,

      "Moving forward

      We began 2024 with positive operational momentum and seek to build on recent achievements to: (i) further expand our healthcare services offerings in the communities we serve, (ii) consider options to reopen or create value from our closed
      RNVA
      abrooklyn abrooklyn 3 minutes ago
      Tyler Technologies Named to America’s Best Midsize Companies List

      Source: Business Wire
      TIME recognizes Tyler on its inaugural 2024 list

      Tyler Technologies, Inc. (NYSE: TYL) was recently recognized on the inaugural list of TIME’s “America’s Best Midsize Companies
      TYL
      Monksdream Monksdream 3 minutes ago
      MIRA yesterday, WRNT this morning’s screamer
      WRNT
      Monksdream Monksdream 3 minutes ago
      MIRA yesterday, WRNT this morning’s screamer
      WRNT
      Awl416 Awl416 4 minutes ago
      LOL
      WRNT
      jrsh jrsh 6 minutes ago
      Why does a company with almost NO BUSINESS AT ALL needs multiple directors in the first place ??? Lol

      Oh wait, i forgot, it's because they can draw nice salaties even when achieving absolutely nothing!!!
      HMNU
      carp302 carp302 8 minutes ago
      So what in the hell is going on with this company?
      AGYP
      QuantumTravesty QuantumTravesty 8 minutes ago
      https://www.otcmarkets.com/otcapi/company/financial-report/407762/content
      HIRU
      LetGoodTimesRoll LetGoodTimesRoll 8 minutes ago
      $RNVA ==>$FOXO ===>NYSE $$$$$$$
      The CINDERELLA of the OTC!
      FOXO RNVA
      Laster Laster 8 minutes ago
      CLRB: $3.02. Biotech stock with "Key Opinion Leader" event tomorrow morning. Last results were really good so expect similar results tomorrow. They use PDC to deliver a radioisotope to treat cancer such as WM (Waldenstrom's Macroglobulinemia). Adapted Radioisotopes specifically targeting cancer cel
      CLRB
      Can'tSparTheGhost Can'tSparTheGhost 8 minutes ago
      Good Morning to ALL & to ALL a Good Day!!!...

      NOW...

      Lets Get Ready To Rumble💥!!!!!!!

      $RNVA🤩
      RNVA
      sin vester sin vester 9 minutes ago
      If this is a Spac then this is ground level of entry. JS
      HIRU
      ChannelTrader ChannelTrader 9 minutes ago
      Biden’s Doctor Releases Health Update 5 Days After He Was Last Seen

      https://truthpress.com/news/bidens-doctor-releases-health-update-5-days-after-he-was-last-seen/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=biden-doctor-issues-update

      President
      Nemesis18 Nemesis18 10 minutes ago
      Large UK Cancer Charities would rather fund perpetual research, for the 'just around the corner treatment' business model is very profitable for them and their Executives.
      NWBO
      Uncle Monkey Uncle Monkey 12 minutes ago
      volume CONFIRMS more bluster from fake news mod..

      obvious to most
      ECSL
      Jake731 Jake731 12 minutes ago
      Good morning all




      TPTW……!!!
      TPTW
      resx18 resx18 14 minutes ago
      Good Morning $CBDW
      CBDW
      imanjen13 imanjen13 15 minutes ago
      Mira traded 30M shares with only 15M outstanding. It was recommended by Zachs on July 19 just before announcing a good trial result.
      I'm expecting daily volume to increase in Elite as well as it attracts new investors who appreciate undervalued gems.
      ELTP
      Nostradamus2012 Nostradamus2012 15 minutes ago
      🍒🍒🍒🍒🍒TESLA🍒🍒🍒🍒🍒
      TSLA
      JJZander JJZander 17 minutes ago
      HIRU filing out
      HIRU

      Your Recent History

      LSE
      0QSS
      Phaxiam Therapeutics
      EU
      WLN
      Worldline
      BOV
      S1BS34M
      Sibanye Stillwater
      BIT
      P1XES7
      NLBNPIT1XES7 20240920 2300
      BIT
      P1XWO8
      NLBNPIT1XWO8 20261231 60
      BIT
      P20IC0
      NLBNPIT20IC0 20991231 58...
      BIT
      P1WX72
      NLBNPIT1WX72 20351221 19...
      NYSE
      ELY
      Callaway Golf
      BOV
      M1MC34
      Marsh E McLennan Cos
      BIT
      P20PE1
      NLBNPIT20PE1 20991231 56...
      Delayed Upgrade Clock